Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/112006
Title: From proteomic analysis to potential therapeutic targets: functional profile of two lung cancer cell lines, A549 and SW900, widely studied in pre-clinical research
Author: Korrodi-Gregório, Luís
Soto Cerrato, Vanessa
Vitorino, Rui
Fardilha, Margarida
Pérez Tomás, Ricardo E.
Keywords: Càncer de pulmó
Proteïnes citosquelètiques
Lung cancer
Cytoskeletal proteins
Issue Date: 4-Nov-2016
Publisher: Public Library of Science (PLoS)
Abstract: Lung cancer is a serious health problem and the leading cause of cancer death worldwide. The standard use of cell lines as in vitro pre-clinical models to study the molecular mechanisms that drive tumorigenesis and access drug sensitivity/effectiveness is of undisputable importance. Label-free mass spectrometry and bioinformatics were employed to study the proteomic profiles of two representative lung cancer cell lines and to unravel the specific biological processes. Adenocarcinoma A549 cells were enriched in proteins related to cellular respiration, ubiquitination, apoptosis and response to drug/hypoxia/oxidative stress. In turn, squamous carcinoma SW900 cells were enriched in proteins related to translation, apoptosis, response to inorganic/organic substances and cytoskeleton organization. Several proteins with differential expression were related to cancer transformation, tumor resistance, proliferation, migration, invasion and metastasis. Combined analysis of proteome and interactome data highlighted key proteins and suggested that adenocarcinoma might be more prone to PI3K/Akt/mTOR and topoisomerase IIα inhibitors, and squamous carcinoma to Ck2 inhibitors. Moreover, ILF3 overexpression in adenocarcinoma, and PCNA and NEDD8 in squamous carcinoma shows them as promising candidates for therapeutic purposes. This study highlights the functional proteomic differences of two main subtypes of lung cancer models and hints several targeted therapies that might assist in this type of cancer.
Note: Reproducció del document publicat a: https://doi.org/10.1371/journal.pone.0165973
It is part of: PLoS One, 2016, vol. 11, num. 11, p. e0165973
Related resource: https://doi.org/10.1371/journal.pone.0165973
URI: http://hdl.handle.net/2445/112006
ISSN: 1932-6203
Appears in Collections:Articles publicats en revistes (Patologia i Terapèutica Experimental)

Files in This Item:
File Description SizeFormat 
665590.pdf5.31 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons